Abstract Doxorubicin (DOX) alone or in combination has been widely used for numerous cancers, including breast, lung, bladder, and so on. In this article, a core/shell/shell structured Fe 3 O 4 @SiO 2 @Au@porous SiO 2 particles for the drug delivery and release of DOX was demonstrated, with the aid of near-infrared irradiation. Fe 3 O 4 was used to direct the transportation and delivery of the drug-loaded composite to the target tissues and organs under an external magnetic field, the first layer of SiO 2 was used for Au nanoparticle attachment, Au acted as the agent for light-thermal conversion, and the porous SiO 2 was used to load DOX. The morphology of the nanoparticles was studied by transmission electron microscopy, and the porous structure was characterized by N 2 adsorption/desorption curves. The drug delivery system displayed high drug loading capacity, and the release behavior was largely impacted by the environmental pH. Furthermore, the cytotoxicity of Fe 3 O 4 @SiO 2 @Au@porous SiO 2 and DOX loaded Fe 3 O 4 @SiO 2 @Au@porous SiO 2 was studied through in vitro 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell viability assay.
Introduction
Cancer has been one of the most devastating diseases nowadays, which has resulted in millions of death all over the world each year. [1] [2] [3] [4] At the current stage, there are still many huge challenges for the treatment of various cancers. Chemotherapy has been considered as an effective method to treat cancers. [5] [6] [7] Among the drugs used for chemotherapy treatment, doxorubicin (DOX) alone or in combination has been widely used for numerous cancers, including breast, lung, bladder, and so on. [8] [9] [10] [11] [12] [13] [14] Doxorubicin can intercalate into DNA and prevent the macromolecular biosynthesis and the growth of cancer cells. 15 However, the side effect of chemotherapy includes high toxicity and damages to healthy tissues and organs. Moreover, another difficulty with conventional chemotherapy is to accumulate chemotherapeutic agents within the cancer tissue and exert the treatment specifically for cancer cells. 15 To solve this problem, the drug delivery system has been proposed and applied to accumulate drugs within the cancer tissues. [16] [17] [18] [19] [20] [21] [22] During the past decades, various nanoparticlebased drug delivery systems incorporating Au nanoparticles have been reported. 23 Within these systems, Au nanoparticles are sensitive to light and display superb light-thermal conversion ability, which makes them a great candidate for lightinduced drug release. 23 Different Au nanostructures that absorb near-infrared (NIR) irradiation have been synthesized, including nanorods, nanocages, nanostars, and so on, and have been prepared. 24 These structures have shown the capabilities of penetrating deep tissues for NIR-induced drug release. For example, Liu et al delivered Au nanoparticle-functioned peptides with loaded drugs to liver cancer cells and investigated the drug release under NIR. 25 Besides, Au nanoparticle-decorated liposomes and polyelectrolytes with various drug lodgings have been synthesized and applied for drug delivery and release. [26] [27] [28] [29] [30] However, the size of most of these capsules is too large for in vivo testing, which limits their further applications within biomedical fields. [31] [32] [33] [34] In this report, we synthesized a novel nanosized Fe 3 O 4 @SiO 2 @Au@porous SiO 2 structure as a drug carrier. Fe 3 O 4 , SiO 2 , and Au all possess low toxicity and high biocompatibility, which make them safe to be used within human organ tissues. The magnetization from Fe 3 O 4 could be used to direct the drug delivery with the aid of an external magnetic field. Due to the inert surface of Fe 3 O 4 , another layer of SiO 2 layer was coated so that Au nanoparticles could be attached. The Au nanoparticles could generate heat within the structure under irradiation due to its superb light-thermal conversion ability. A final layer of porous SiO 2 was coated to prevent the detachment of Au nanoparticles and load drugs. A porous structure was able to provide a large surface area for drug loading. C. 35 SiO 2 was coated on Fe 3 O 4 particles through a modified Stober method. Specifically, Fe 3 O 4 (0.1 g) was mixed in ethanol (100 mL) and ammonia solution (28%, 5 mL) with mechanical stirring. Tetraethyl orthosilicate (0.1 mL) was introduced into the solution every 10 minutes until the total volume reaches 1 mL. After cleaning with ethanol and DI water, the particles with SiO 2 layer of *20 nm were dispersed in isopropanol (80 mL) and 3-aminopropyl-triethoxysilane (APTS, 200 mL) at 75 C for 1 hour so that the amino groups could be grafted to SiO 2 surface. Separately, the Au nanoparticles were synthesized through a Turkevich synthesis. *60 000) were mixed in 100 mL water and ultrasonicated for 10 minutes so that the polymer could be adsorbed on the surface of the particles. The colloids were then washed with DI water and introduced into a solution of ethanol (100 mL) and ammonia solution (28%, 5 mL). Tetraethyl orthosilicate (0.1 mL) was introduced into the dispersion every 10 minutes until the total volume reaches 1 mL. Finally, Fe 3 O 4 @SiO 2 @Au@SiO 2 nanoparticles with external SiO 2 layer of *20 nm were obtained.
Synthesis of Fe 3 O 4 @SiO 2 @Au@p-SiO 2
The external layer of SiO 2 in Fe 3 O 4 @SiO 2 @Au@SiO 2 was etched into a porous structure so that Fe 3 O 4 @SiO 2 @Au@p-SiO 2 could be prepared. Specifically, Fe 3 O 4 @SiO 2 @Au@SiO 2 (0.1 g) and PVP (1 g, Mw: *10 000) were mixed in 100 mL DI water and refluxed at 100 C for 5 hours. After cooling down to room temperature, NaOH solution (0.32 g/mL, 5 mL) was introduced to the suspension under magnetic stirring. After stirring for 10 minutes, the solution pH was quickly regulated to 7 with dilute HCl to quench the etching reaction. The particles were washed with DI water, and Fe 3 O 4 @SiO 2 @Au@p-SiO 2 particles were obtained.
Synthesis of Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX
Fe 3 O 4 @SiO 2 @Au@p-SiO 2 particles (0.1 g) and DOX water solution (500 mg/mL, 50 mL) were stirred and shaken at room temperature for 24 hours in the dark. The final concentration of DOX could be determined by ultraviolet-visible (UV-Vis) spectroscopy. The loaded DOX could be calculated with the concentration difference.
Materials Characterization
The morphology of the particles was studied by transmission electron microscopy (TEM; Hitachi HT7700), and the crystal structure was determined by X-ray diffraction (XRD; Bruker D8). The surface area of the particles was investigated by N 2 adsorption-desorption isotherm curves. The existence of DOX on particle surface was determined by fluorescence spectroscopy (USB2000þ; Ocean Optics).
Near-Infrared-Induced Drug Release With Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX Near-infrared-induced DOX dry delivery and release were studied by the dialysis method. Briefly, Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX (40 mg) was filled in a dialysis bag, which was then exposed in a phosphate buffer saline (0.1 mol/L, 100 mL) at 37 C, and the pH was regulated based on the experimental design. The DOX-loaded system was exposed to NIR laser at 808 nm (P ¼ 5, 7.5, and 10 W/cm 2 ) under stirring so that light-thermal conversion could be achieved. During the drug release, a sample solution (5 mL) was taken out every 25 minutes to determine the DOX concentration by UV-Vis spectroscopy. After the measurement, the sample solution was returned to the solution container.
In Vivo MTT Assay C6 glioma cells were selected for cytotoxicity testing due to its wide availability and widely used for cytotoxicity investigation.
38 C6 glioma cells were seeded in a 96-well culture plate with 10% fetal bovine serum for 12 hours. The chamber was heated to 37 C and filled with 5% CO 2 , and the cell density was controlled at 10 000 cells/well. The medium was 100 mL of Dulbecco Modified Eagle medium. Both DOX and Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX were dispersed in 100 mL culture medium, respectively, and then introduced into each well. Six wells without DOX or Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX were used as the control experiments. After incubation for 72 hours, the cytotoxicity was studied by MTT assay. The cell survival rate was calculated. The cytotoxicity of Fe 3 O 4 @SiO 2 @Au@p-SiO 2 alone was also evaluated in a similar way.
Results and Discussion
The TEM image of Fe 3 O 4 particles is presented in Figure 1A . It is observed that the particles are spherical, with a size around 50 nm. After coating a thin layer of SiO 2 and coupling agent of APTS on the surface of Fe 3 O 4 , Au nanoparticles were adsorbed on the SiO 2 surface due to the chemical interaction between Au and amine functional groups from APTS, and the corresponding TEM image of Fe 3 O 4 @SiO 2 @Au nanoparticles is presented in Figure 1B . With the presence of PVP, another layer of SiO 2 was coated on the outer layer of Fe 3 O 4 @SiO 2 @Au so that Au nanoparticles are fully encapsulated. Mesoporous structure of the outer SiO 2 is generated by protecting the near-surface layer of SiO 2 by PVP and etching the outer layer of SiO 2 in NaOH solution. Refluxing the particles in PVP solution results in the penetration of PVP into the SiO 2 surface by generating hydrogen bonds between carbonyl groups and silanol groups. 39 The polymer chains within SiO 2 could dramatically increase its stability in NaOH solution, while the regions without PVP protections would be easily etched by NaOH. Therefore, a porous structure of the outer SiO 2 layer is formed. Finally, Fe 3 O 4 @-SiO 2 @Au@p-SiO 2 is synthesized, as shown in Figure 1C . A porous structured SiO 2 at the outer layer could provide a larger surface area for DOX loading. The general nanoparticle synthesis and DOX loading process are summarized in Figure 1D .
The porous nature of the outer SiO 2 layer could provide a larger surface area for DOX loading. To verify the surface area change before and after the formation of the porous structure, the N 2 adsorption/desorption curves for Fe 3 O 4 @SiO 2 @Au@SiO 2 and Fe 3 O 4 @SiO 2 @Au@p-SiO 2 are presented in Figure 2A . In Fe 3 O 4 @SiO 2 @Au@p-SiO 2 , the large hysteresis between adsorption and desorption curves indicates its porous structure. The specific surface area of Fe 3 O 4 @SiO 2 @Au@SiO 2 and Fe3O 4 @SiO 2 @Au@p-SiO 2 is calculated as 87.5 and 143.5 m 2 /g, respectively. It is observed that the porous structure could increase the specific surface area by 64%. The corresponding pore size distribution is presented in Figure 2B . The peak pore size is increased from 3.8 to 9.8 nm. Previous research shows that the diameter of DOX molecules is *1.5 nm. 40 Therefore, the pore size is large enough to hold DOX molecules.
The electron paramagnetic resonance spectroscopy is used to study the magnetic properties of Fe 3 O 4 , Fe 3 O 4 @SiO 2 @Au, and Fe 3 O 4 @SiO 2 @Au@p-SiO 2 , and the corresponding spectra are presented in Figure 2C . It shows that, after introducing different materials into Fe 3 O 4 , both peak intensity and width change, indicating the change in spin states within the particles, are attributed to the different environment of the magnetic phase, while the magnetization is still available within the composites, which is featured with the existence of peak in the spectra.
Fluorescence spectrum is applied to investigate the DOX loading behavior on Fe 3 O 4 @SiO 2 @Au@p-SiO 2 , and the corresponding fluorescence spectra for Fe 3 Figure 2D . It can be seen that there is no peak observed due to the absence of DOX. To investigate the application of NIR-induced drug release, the temperature under different power of laser and irradiation time is presented in Figure 4A -C. In each experiment, the Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX concentration is controlled as 25, 50, and 100 mg/mL. Under a specific laser power, it is observed that a higher concentration of The impacts of pH on DOX release is also studied, and the results are presented in Figure 4D . First, the DOX release is studied under different pH without NIR irradiation, and the pH is controlled as 5.4, 6.4, and 7.4. It is observed that the DOX release is fast at the earlier stage and then slows down gradually. After releasing for 300 minutes, the accumulative DOX release reaches 18.3%, 31.2%, and 37.7% under the pH of 7.4, 6.4 and 5.4, respectively. This result indicates that a lower pH is beneficial for the fast delivery of DOX with the platform of Fe 3 O 4 @SiO 2 @Au@p-SiO 2 . This discovery could be used to guide the local pH regulation when releasing DOX into tumor tissue in the pathological process.
After that, NIR irradiation (10 W/cm 2 ) is applied to Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX release under the pH of 5.4. After 300 minutes of irradiation, the accumulative DOX release reaches 65.3%, which is almost twice of the condition without NIR irradiation. This result concludes that NIR irradiation plays a critical role in releasing DOX from Fe 3 O 4 @SiO 2 @Au@p-SiO 2 platform.
As a platform for drug delivery and release, its toxicity needs to be well evaluated, which is performed through standard MTT cell viability assay. As shown in Figure 5A, Figure 4B . Generally, Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX has lower toxicity than pure DOX. This is could be attributed to the loading ratio in Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX (the mass ratio of Fe 3 O 4 @SiO 2 @Au@p-SiO 2 ), and the real DOX concentration in Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX experiment is much lower than that in pure DOX. In Fe 3 O 4 @SiO 2 @Au@p-SiO 2 -DOX experiment, even when its concentration reaches 100 mg/mL, the C6 cell viability could be maintained as high as *50%, indicating its relatively low toxicity to the cells.
Conclusions
Fe 3 O 4 @SiO 2 @Au@p-SiO 2 nanoparticles were synthesized, and DOX was attached to the particle surface. The BET method study indicated that the particles have a porous structure, which was beneficial to load DOX. The drug delivery and release were studied under NIR irradiation. The impacts of laser power and environmental pH on drug delivery and release were investigated. The study indicated that a lower pH and higher power of laser were beneficial for DOX drug release. Finally, the cytotoxicity of both 
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